Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

17

Revenue 2017

Allergan

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Allergan's 2013 CNS (central nervous system) sales performance.

Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture

Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture Meanwhile, off-label use of Roche’s VEGF inhibitor Avastin (bevacizumab) continues to be a low-cost alternative to the approved treatments for wet AMD, while Allergan has a new

Why Marry?

Why Marry? Both of Pfizer’s deals, therefore, have similar motivations. Compare this with the AbbVie/ Allergan deal which, while offering some scale, scope and market power, is also driven by the need ... AbbVie will succeed if it uses the time Allergan gives it

AbbVie/Allergan's merger faces public opposition

AbbVie/Allergan's merger faces public opposition The merger, noted in the letter, will make AbbVie/Allergan the fourth largest pharmaceutical company. ... the Allergan deal has a different purpose – allowing it to gain “critical mass” in its growth platform.

Roche preps filings for Herceptin/Perjeta combination

Roche preps filings for Herceptin/Perjeta combination IV Herceptin biosimilars from Amgen/Allergan have also been recently launched in the US at a 15% discount to Roche’s list price for the drug.

Strike three for Rova-T has AbbVie cutting its losses

Strike three for Rova-T has AbbVie cutting its losses In June it agreed to acquire Allergan in a  $63bn deal that adds $16bn in annual sales from products like wrinkle treatment Botox, diversifying its revenue stream.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics